Sharon A Hunt

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi The changing face of heart transplantation
    Sharon A Hunt
    Division of Cardiovascular Medicine, Stanford University, Palo Alto, California 94305, USA
    J Am Coll Cardiol 52:587-98. 2008
  2. ncbi Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study
    William F Fearon
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305 5637, USA
    J Heart Lung Transplant 25:765-71. 2006
  3. ncbi Changes in coronary anatomy and physiology after heart transplantation
    Atsushi Hirohata
    Center for Research in Cardiovascular Interventions, Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California, USA
    Am J Cardiol 99:1603-7. 2007
  4. ncbi Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience
    Nobuyuki Shiba
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    J Heart Lung Transplant 23:155-64. 2004
  5. ncbi Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era
    Nobuyuki Shiba
    Division of Cardiovascular Medicine, Falk Cardiovascular Research Building, Stanford University Medical Center, 300 Pasteur Drive, Palo Alto, CA 94305, USA
    J Heart Lung Transplant 22:1098-106. 2003
  6. ncbi Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience
    Bernard Cantin
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Heart Lung Transplant 22:723-30. 2003
  7. doi Clinical and functional correlates of early microvascular dysfunction after heart transplantation
    Francois Haddad
    Department of Medicine, Stanford University, Stanford, CA, USA
    Circ Heart Fail 5:759-68. 2012
  8. doi Changing trends in infectious disease in heart transplantation
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford University, Stanford, California 94305, USA
    J Heart Lung Transplant 29:306-15. 2010
  9. doi Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University, 770 Welch Rd, Ste 400, Palo Alto, CA 94304 5715, USA
    Circulation 117:1717-31. 2008
  10. ncbi Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature
    Francois Haddad
    Heart Failure, Heart Transplant and Pulmonary Hypertension Service, Stanford University Medical Center, Palo Alto, California 94304 5715, USA
    J Heart Lung Transplant 26:93-7. 2007

Detail Information

Publications47

  1. ncbi The changing face of heart transplantation
    Sharon A Hunt
    Division of Cardiovascular Medicine, Stanford University, Palo Alto, California 94305, USA
    J Am Coll Cardiol 52:587-98. 2008
    ..Topics that will be covered in this review include the changing patient population as well as recent advances in transplantation immunology, organ preservation, allograft vasculopathy, and immune tolerance...
  2. ncbi Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study
    William F Fearon
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305 5637, USA
    J Heart Lung Transplant 25:765-71. 2006
    ....
  3. ncbi Changes in coronary anatomy and physiology after heart transplantation
    Atsushi Hirohata
    Center for Research in Cardiovascular Interventions, Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California, USA
    Am J Cardiol 99:1603-7. 2007
    ..5 +/- 10.5%, p = NS). In conclusion, early after HT, anatomic and physiologic evidence of epicardial CAV was found. Later after HT, the physiologic effect of epicardial CAV may be less, because of increased microvascular dysfunction...
  4. ncbi Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience
    Nobuyuki Shiba
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    J Heart Lung Transplant 23:155-64. 2004
    ..Truly long term survival post heart transplantation has become increasingly frequent over the past two decades...
  5. ncbi Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era
    Nobuyuki Shiba
    Division of Cardiovascular Medicine, Falk Cardiovascular Research Building, Stanford University Medical Center, 300 Pasteur Drive, Palo Alto, CA 94305, USA
    J Heart Lung Transplant 22:1098-106. 2003
    ..The purpose of this study is to identify factors associated with 10-year survival after heart transplantation...
  6. ncbi Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience
    Bernard Cantin
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Heart Lung Transplant 22:723-30. 2003
    ..The present study was undertaken to determine whether a late conversion to tacrolimus affords these benefits to heart transplant recipients...
  7. doi Clinical and functional correlates of early microvascular dysfunction after heart transplantation
    Francois Haddad
    Department of Medicine, Stanford University, Stanford, CA, USA
    Circ Heart Fail 5:759-68. 2012
    ..The objective of the study was to determine the risk factors and functional correlates associated with early microvascular dysfunction in heart transplant recipients...
  8. doi Changing trends in infectious disease in heart transplantation
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford University, Stanford, California 94305, USA
    J Heart Lung Transplant 29:306-15. 2010
    ..This study presents a historical perspective of the changing trends of infectious disease after heart transplantation...
  9. doi Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University, 770 Welch Rd, Ste 400, Palo Alto, CA 94304 5715, USA
    Circulation 117:1717-31. 2008
  10. ncbi Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature
    Francois Haddad
    Heart Failure, Heart Transplant and Pulmonary Hypertension Service, Stanford University Medical Center, Palo Alto, California 94304 5715, USA
    J Heart Lung Transplant 26:93-7. 2007
    ..We also review the differences between Pneumocystis jiroveci prophylaxis regimens with respect to concomitant prophylaxis of Nocardia and other opportunistic infections...
  11. ncbi Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy
    Jennifer A Tremmel
    Division of Cardiovascular Medicine, Stanford University School of Medicine, California, USA
    Am J Cardiol 108:665-8. 2011
    ....
  12. ncbi Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study)
    William F Fearon
    Division of Cardiovascular Medicine, Stanford University Medical Center, 300 Pasteur Drive, Stanford, Calif 94305, USA
    Circulation 108:1605-10. 2003
    ..We evaluated a new method for simultaneously measuring FFR and CFR with a single wire to investigate transplant arteriopathy...
  13. ncbi Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation
    Ombretta Biadi
    Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
    J Heart Lung Transplant 26:324-30. 2007
    ..Although systemic inflammation, as detected by C-reactive protein (CRP), predicts CAV development, the relationship between CRP and markers of metabolic abnormalities remains unexplored...
  14. ncbi Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy
    Francois Haddad
    Department of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    J Heart Lung Transplant 25:1367-70. 2006
    ..We report 2 cases of cardiac allograft vasculopathy associated with giant coronary aneurysms. To our knowledge, these are the first reported cases of spontaneous giant coronary aneurysms in heart transplant recipients...
  15. doi Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle
    Francois Haddad
    Division of Cardiovascular Medicine, Stanford University, 770 Welch Rd, Suite 400, Palo Alto, CA 94304 5715, USA
    Circulation 117:1436-48. 2008
  16. ncbi Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation
    Leon M Ptaszek
    Department of Internal Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
    Heart Rhythm 2:931-3. 2005
    ..There are no data on the usefulness of implantable cardioverter-defibrillators (ICDs) in this population; therefore, we report our early experience with ICD placement in such patients...
  17. ncbi Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis
    Suman S Kuppahally
    Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
    J Heart Lung Transplant 25:144-7. 2006
    ..The patient has been stable on treatment with regular phlebotomies and a low vitamin C diet...
  18. doi [Tratamiento basado en la evidencia de la insuficiencia cardiaca derecha: una revisión sistemática de un campo empírico]
    Mehdi Skhiri
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California, United States
    Rev Esp Cardiol (Engl Ed) 63:451-71. 2010
    ..Emerging new therapies, such as metabolic modulators, and the perils and pitfalls of managing right heart failure are also discussed in the article. ..
  19. ncbi Effect of a change in gender on coronary arterial size: a longitudinal intravascular ultrasound study in transplanted hearts
    Niall A Herity
    Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
    J Am Coll Cardiol 41:1539-46. 2003
    ..We sought to document whether a physiologic change in gender has any effect on coronary arterial size...
  20. ncbi Cardiac xenotransplantation
    Michael X Pham
    Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94304 5406, USA
    Coron Artery Dis 15:99-105. 2004
  21. ncbi Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility
    Melinda L Telli
    Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA
    J Clin Oncol 25:3525-33. 2007
    ..To assess the spectrum and reversibility of the cardiotoxicity observed in the adjuvant trastuzumab trials...
  22. ncbi Malignancy in organ transplantation: heart
    Sharon A Hunt
    Department of Cardiovascular Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Transplant Proc 34:1874-6. 2002
  23. ncbi Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection
    Bernard Cantin
    Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Clin Transplant 16:196-201. 2002
    ..The current study was undertaken to determine if such monitoring is still useful more than 1 yr after heart transplantation...
  24. ncbi Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation
    Seema S Sinha
    Department of Internal Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Am Heart J 155:889.e1-6. 2008
    ..Rapamycin has been shown to reduce anatomical evidence of cardiac allograft vasculopathy, but its effect on coronary artery physiology is unknown...
  25. ncbi Mechanical circulatory support: new data, old problems
    Sharon A Hunt
    Circulation 116:461-2. 2007
  26. ncbi Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease
    Tomoko Kato
    Department of Cardiology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    J Am Coll Cardiol 43:1034-41. 2004
    ..The possible effect of plasma hemoglobin A(1c) (HbA(1c)) on the development of transplant coronary artery disease (TxCAD) was investigated...
  27. ncbi Long-term results of heart transplantation in patients older than 60 years
    Philippe Demers
    Department of Cardiothoracic Surgery, Stanford University School of Medicine, CA 94305 5247, USA
    J Thorac Cardiovasc Surg 126:224-31. 2003
    ..Older patients are now considered as potential candidates for heart transplantation. The objective of this study was to evaluate the long-term results of heart transplantation in patients older than 60 years...
  28. ncbi The economic implications of noninvasive molecular testing for cardiac allograft rejection
    Roger W Evans
    Am J Transplant 5:1553-8. 2005
    ....
  29. ncbi ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise
    Lee A Fleisher
    J Am Coll Cardiol 50:1707-32. 2007
  30. doi ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise
    Lee A Fleisher
    Anesth Analg 106:685-712. 2008
  31. doi ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline
    Andrew E Epstein
    Circulation 117:e350-408. 2008
  32. ncbi 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaborat
    Elliott M Antman
    Circulation 117:296-329. 2008
  33. ncbi ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guideline
    Lee A Fleisher
    J Am Coll Cardiol 50:e159-241. 2007
  34. ncbi ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guideline
    Lee A Fleisher
    Society for Vascular Medicine and Biology
    Circulation 116:e418-99. 2007
  35. ncbi ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise
    Lee A Fleisher
    Circulation 116:1971-96. 2007
  36. ncbi The impact of brain death on survival after heart transplantation: time is of the essence
    Bernard Cantin
    Quebec Heart Institute, Quebec City, Quebec, Canada
    Transplantation 76:1275-9. 2003
    ..It has been suggested that the modality of brain death and time from brain death until harvest impact survival and rejection after heart transplantation...
  37. ncbi ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary
    Sharon A Hunt
    American College of Cardiology American Heart Association Task Force on Practice Guidelines
    J Heart Lung Transplant 21:189-203. 2002
  38. ncbi ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Sur
    Alan T Hirsch
    Circulation 113:e463-654. 2006
  39. ncbi ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideli
    Lee A Fleisher
    J Am Coll Cardiol 47:2343-55. 2006
  40. ncbi Taking heart--cardiac transplantation past, present, and future
    Sharon A Hunt
    Stanford University School of Medicine, Stanford, Calif, USA
    N Engl J Med 355:231-5. 2006
  41. ncbi ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Societ
    Douglas P Zipes
    Eur Heart J 27:2099-140. 2006
  42. ncbi ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com
    Douglas P Zipes
    France
    Europace 8:746-837. 2006
  43. ncbi ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com
    Douglas P Zipes
    J Am Coll Cardiol 48:e247-346. 2006
  44. ncbi Prevalence, patterns of development, and prognosis of right bundle branch block in heart transplant recipients
    Gregory M Marcus
    Division of Cardiology, Electrophysiology Section, University of California, San Francisco, San Francisco, California, USA
    Am J Cardiol 98:1288-90. 2006
    ..The cause of RBBB appears to be largely related to events that occur well after transplantation, and the prognosis is benign...
  45. ncbi ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideli
    Lee A Fleisher
    Circulation 113:2662-74. 2006
  46. ncbi ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise th
    Jeffrey L Anderson
    J Am Coll Cardiol 50:e1-e157. 2007
  47. ncbi Heart failure management: caregiver versus care plan
    Daniel H Kim
    Circulation 108:129-31. 2003